Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1058 | 968 | 1099 | 1148 | 1447 | 2012 |
Fund Return | 5.83% | -3.21% | 9.91% | 4.7% | 7.68% | 7.24% |
Place in category | 353 | 257 | 382 | 283 | 213 | 160 |
% in Category | 60 | 39 | 66 | 54 | 42 | 49 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Russell Investments World Equity FR | 1.52B | 21.24 | 7.52 | 9.36 | ||
Russell Investments World Equity FC | 1.52B | 21.80 | 8.06 | 10.25 | ||
Russell Investments World Equity FF | 723.84M | 20.70 | 7.46 | 9.47 | ||
Acadian Global Equity UCITS A EUR A | 674.17M | 32.45 | 13.18 | 12.53 | ||
Russell Investments Global Listed E | 223.3M | 13.14 | 9.04 | 7.00 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
IE00BD0NCR01 | 2.56B | 7.84 | 5.54 | - | ||
Continental European Equity ClassEA | 669.87M | 12.24 | 6.63 | 9.71 | ||
Continental European Equity Class E | 669.87M | 10.20 | 4.06 | 8.51 | ||
Continental European Equity Class Z | 669.87M | 10.81 | 4.69 | 9.16 | ||
Continental European Equity Class C | 669.87M | 9.50 | 3.34 | 7.77 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Novo Nordisk B | DK0062498333 | 3.14 | 589.2 | -20.72% | |
SAP | DE0007164600 | 2.50 | 236.750 | -0.13% | |
ASML Holding | NL0010273215 | 2.26 | 686.10 | -0.68% | |
Sanofi | FR0000120578 | 2.09 | 91.28 | -0.24% | |
Roche Holding Participation | CH0012032048 | 2.08 | 247.40 | +0.28% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Neutral | Buy | Strong Buy |
Technical Indicators | Sell | BUY | Strong Buy |
Summary | Neutral | Buy | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review